Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol oil for treatment-resistant major depressive disorder
RBR-6n6wzsxNot yet recruiting
- Sponsor
- Estácio
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in major depressive disorder (MDD) comparing Cannabidiol oil + stable antidepressants with Placebo + stable antidepressants (2 arms). Planned start May 2026; status: not yet recruiting.
02
Drugs
cannabidiol
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on RBR-6n6wzsx.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6n6wzsx.